Beone Medicines Ltd. Class A · SSE:688235
Oyler John sold 1,949 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Oyler John (Director, Chief Executive Officer) sold 1,949 Beone Medicines Ltd. Class A shares at an average US$257.24 for US$501K, leaving 0 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 1,949 shares
- Price
- US$257.24 average (US$256.23 to US$258.81)
- Value
- US$501K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ordinary Shares | Award | 177,931 | 5,697,649 | Direct | |
| Jun 11, 2026 | American Depositary Shares | Sale | 741 | US$256.23 | 1,208 | Direct |
| Jun 11, 2026 | American Depositary Shares | Sale | 859 | US$257.59 | 349 | Direct |
| Jun 11, 2026 | American Depositary Shares | Sale | 200 | US$258.28 | 149 | Direct |
| Jun 11, 2026 | American Depositary Shares | Sale | 149 | US$258.81 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Oyler John
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Oyler John · Aug 12, 2026
- Form 4 · Oyler John · Jul 22, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026